ARCHIVES

Authorizes $2.7 Billion For NCI, 7% Prevention

This article is from The Cancer Letter archive.

Vol. 19 No. 22 | May 28, 1993

Download PDF Visit The Full Archive

Related Articles

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

July 3, 1998

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980